HCA Healthcare (NYSE:HCA – Get Rating) had its target price reduced by Truist Financial from $310.00 to $250.00 in a report released on Monday, The Fly reports. Truist Financial’s price objective would suggest a potential upside of 16.90% from the stock’s previous close. A number of other research firms also recently weighed in on HCA. […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price target decreased by equities research analysts at Wells Fargo & Company from $267.00 to $227.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price objective dropped by equities researchers at Cowen from $265.00 to $241.00 in a note issued to investors on Monday, Stock Target Advisor reports. Cowen’s price objective would indicate a potential upside of 13.54% from the stock’s current price. HCA has been the subject of several other […]
HCA Healthcare (NYSE:HCA – Get Rating) had its price target reduced by investment analysts at Jefferies Financial Group from $310.00 to $275.00 in a research report issued on Monday, The Fly reports. Jefferies Financial Group’s target price would indicate a potential upside of 31.63% from the stock’s previous close. Other research analysts also recently issued […]
HCA Healthcare (NYSE:HCA – Get Rating) issued an update on its FY 2022 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $16.400-$17.600 for the period, compared to the Thomson Reuters consensus estimate of $18.930. The company issued revenue guidance of $59.50 billion-$61.50 billion, compared to the consensus revenue estimate […]